Smithkline Beecham Corporation

Gary Thomas Borrett

John Kitteringham

Rodney C Young

Roderick Alan Porter

Mythily Vimal

Mark R Shipton

Steven Mark Bromidge

Erol A Faruk

Mark Jason Hughes

Martyn Voyle

John Keogh

A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate, or hydtrate thereof, processes for preparing said compounds and pharmaceutical compostions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.

Enantiomer of carbazole derivative as 5-HT1-like agonists

A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists. ##STR1##

Process for preparing enantiomers of carbazole derivatives as 5-HT.sub.1

A process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein R.sub.1 represents ##STR2## in which r represents an integer of 2 to 4, s represents 1 or 2 and t represents 0 or 1;

Process for the preparation of azabicycloc derivatives

Derivatives of quinuclidine n-oxide as muscarinic receptor ligands

##STR1## A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.

Enantiomers of carbazole derivatives as 5-HT.sub. 1-like agonists

Process for preparing an enantiomer of a carbazole derivative

Process of preparing enantiomers of carbazole derivatives

A (+)or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.

Enantiomers of carbazole derivatives as 5-HT.sub.1 -like agonists

Growing community of inventors

Stansted, United Kingdom

Gary Thomas Borrett